These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 1493851

  • 61. Pharmacokinetics of the active metabolite of benazepril, benazeprilat, and inhibition of plasma angiotensin-converting enzyme activity after single and repeated administrations to dogs.
    King JN, Mauron C, Kaiser G.
    Am J Vet Res; 1995 Dec; 56(12):1620-8. PubMed ID: 8599524
    [Abstract] [Full Text] [Related]

  • 62. Phase I and pharmacokinetic study of the oral farnesyl transferase inhibitor SCH 66336 given twice daily to patients with advanced solid tumors.
    Eskens FA, Awada A, Cutler DL, de Jonge MJ, Luyten GP, Faber MN, Statkevich P, Sparreboom A, Verweij J, Hanauske AR, Piccart M, European Organization for Research and Treatment of Cancer Early Clinical Studies Group.
    J Clin Oncol; 2001 Feb 15; 19(4):1167-75. PubMed ID: 11181683
    [Abstract] [Full Text] [Related]

  • 63. The effect of sabeluzole (R 58735) on memory retrieval functions.
    Tritsmans L, Clincke G, Amery WK.
    Psychopharmacology (Berl); 1988 Feb 15; 94(4):527-31. PubMed ID: 3131798
    [Abstract] [Full Text] [Related]

  • 64. Pharmacokinetic and pharmacodynamic studies of the histamine H1-receptor antagonist ebastine in dogs.
    Puigdemont A, Queralt M, Jansat JM, Martinez-Tobed A.
    J Pharm Pharmacol; 1994 Jul 15; 46(7):596-9. PubMed ID: 7996390
    [Abstract] [Full Text] [Related]

  • 65. Single and multiple-dose pharmacokinetics of meloxicam after oral administration to the rabbit (Oryctolagus cuniculus).
    Carpenter JW, Pollock CG, Koch DE, Hunter RP.
    J Zoo Wildl Med; 2009 Dec 15; 40(4):601-6. PubMed ID: 20063804
    [Abstract] [Full Text] [Related]

  • 66. Chronic treatment with sabeluzole protects cultured rat brain neurons from the neurotoxic effects of excitatory amino acids.
    Pauwels PJ, Van Assouw HP, Peeters L, Moeremans M, Leysen JE.
    Synapse; 1992 Dec 15; 12(4):271-80. PubMed ID: 1361247
    [Abstract] [Full Text] [Related]

  • 67. Pharmacokinetics of Cromolyn and Ibuprofen in Healthy Elderly Volunteers.
    Brazier D, Perry R, Keane J, Barrett K, Elmaleh DR.
    Clin Drug Investig; 2017 Nov 15; 37(11):1025-1034. PubMed ID: 28856569
    [Abstract] [Full Text] [Related]

  • 68.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 69. Pharmacokinetics of diphemanil methylsulphate in infants.
    Vidal AM, Chéron G, Rey E, Pons G, d'Athis P, Olive G.
    Eur J Clin Pharmacol; 1993 Nov 15; 45(1):89-91. PubMed ID: 8405036
    [Abstract] [Full Text] [Related]

  • 70. Single-dose and steady-state pharmacokinetics of sabeluzole in senile dementia of Alzheimer type patients.
    De Deyn PP, Van de Velde V, Verslegers W, Saerens J, Pickut BA, Clincke B, Woestenborghs R, Van Peer A.
    Eur J Clin Pharmacol; 1992 Nov 15; 43(6):661-2. PubMed ID: 1493851
    [Abstract] [Full Text] [Related]

  • 71. Pharmacokinetics of sabeluzole and dextromethorphan oxidation capacity in patients with severe hepatic dysfunction and healthy volunteers.
    Pageaux GP, Micallef J, Nataf MB, Levron JC, Lacarelle B, Le Moing JP, Bouhours P, Blin O.
    Br J Clin Pharmacol; 2001 Feb 15; 51(2):164-8. PubMed ID: 11259989
    [Abstract] [Full Text] [Related]

  • 72. Effect of age and gender on the pharmacokinetics of ebastine after single and repeated dosing in healthy subjects.
    Rohatagi S, Gillen M, Aubeneau M, Jan C, Pandit B, Jensen BK, Rhodes G.
    Int J Clin Pharmacol Ther; 2001 Mar 15; 39(3):126-34. PubMed ID: 11396753
    [Abstract] [Full Text] [Related]

  • 73. Pharmacokinetics of dexloxiglumide after administration of single and repeat oral escalating doses in healthy young males.
    Persiani S, D'Amato M, Makovec F, Tavares IA, Bishai PM, Rovati LC.
    Int J Clin Pharmacol Ther; 2002 May 15; 40(5):198-206. PubMed ID: 12051571
    [Abstract] [Full Text] [Related]

  • 74.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 75. Single-dose and steady-state pharmacokinetics of sabeluzole in senile dementia of Alzheimer type patients.
    De Deyn PP, Van de Velde V, Verslegers W, Saerens J, Pickut BA, Clincke B, Woestenborghs R, Van Peer A.
    Eur J Clin Pharmacol; 1992 May 15; 43(6):661-2. PubMed ID: 1493851
    [Abstract] [Full Text] [Related]

  • 76. Pharmacokinetics of sabeluzole and dextromethorphan oxidation capacity in patients with severe hepatic dysfunction and healthy volunteers.
    Pageaux GP, Micallef J, Nataf MB, Levron JC, Lacarelle B, Le Moing JP, Bouhours P, Blin O.
    Br J Clin Pharmacol; 2001 Feb 15; 51(2):164-8. PubMed ID: 11259989
    [Abstract] [Full Text] [Related]

  • 77.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 78. Pharmacokinetics of dexloxiglumide after administration of single and repeat oral escalating doses in healthy young males.
    Persiani S, D'Amato M, Makovec F, Tavares IA, Bishai PM, Rovati LC.
    Int J Clin Pharmacol Ther; 2002 May 15; 40(5):198-206. PubMed ID: 12051571
    [Abstract] [Full Text] [Related]

  • 79. Pharmacokinetics of lubeluzole (Prosynap) after single intravenous doses in healthy subjects.
    Van de Velde V, Crabbe R, Van Peer A, Woestenborghs R, Van Osselaer N, Hantson L, Heykants J.
    Int J Clin Pharmacol Ther; 1998 Sep 15; 36(9):490-3. PubMed ID: 9760010
    [Abstract] [Full Text] [Related]

  • 80. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.
    McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM.
    Neurology; 1984 Jul 15; 34(7):939-44. PubMed ID: 6610841
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.